Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Precigen (NASDAQ:PGEN) in the last three months. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Analysts’ evaluations of 12-month price targets offer additional insights, showcasing an average target of $8.2, with a high estimate of $14.00 and a low estimate of $4.00. A 12.77% drop is evident in the current average compared to the previous average price target of $9.40. Deco…